Zhenfeng Duan Selected Research

Osteosarcoma (Osteogenic Sarcoma)

5/2022	Expression and Clinical Significance of High-Mobility Group AT-hook 2 (HMGA2) in Osteosarcoma.
1/2022	SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
12/2021	T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
1/2021	Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma.
12/2020	PTEN in osteosarcoma: Recent advances and the therapeutic potential.
11/2020	Expression and clinical implications of leucine-rich repeat containing 15 (LRRC15) in osteosarcoma.
10/2020	MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.
1/2020	Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma.
1/2020	Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.
1/2020	Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenfeng Duan Research Topics

Disease

116	Neoplasms (Cancer) 05/2022 - 10/2000
59	Osteosarcoma (Osteogenic Sarcoma) 05/2022 - 01/2009
35	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2003
27	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 08/2009
20	Chordoma 12/2020 - 06/2009
19	Neoplasm Metastasis (Metastasis) 05/2022 - 07/2014
11	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2005
9	Carcinogenesis 02/2022 - 05/2015
7	Chondrosarcoma 01/2021 - 09/2009
6	Liposarcoma 01/2022 - 01/2014
5	Synovial Sarcoma (Synovioma) 05/2022 - 01/2016
5	Carcinoma (Carcinomatosis) 01/2020 - 01/2003
4	Necrosis 01/2020 - 07/2014
3	Ewing Sarcoma (Sarcoma, Ewing) 04/2019 - 09/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016 - 11/2012
3	Hypoxia (Hypoxemia) 02/2011 - 01/2011
3	Adenocarcinoma 06/2010 - 05/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2019
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 07/2003
2	Intervertebral Disc Degeneration 10/2016 - 01/2016
2	Body Weight Changes 10/2015 - 05/2008
2	Retinoblastoma (Glioblastoma, Retinal) 01/2015 - 06/2012
2	Prostatic Neoplasms (Prostate Cancer) 11/2012 - 11/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2012 - 11/2008

Drug/Important Bio-Agent (IBA)

43	Pharmaceutical PreparationsIBA 01/2021 - 10/2000
39	Small Interfering RNA (siRNA)IBA 05/2022 - 07/2004
32	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2003
30	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2004
27	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2009
22	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2003
16	MicroRNAs (MicroRNA)IBA 02/2022 - 06/2010
15	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2022 - 01/2014
10	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2000
10	Phosphotransferases (Kinase)IBA 03/2018 - 04/2010
9	Biological ProductsIBA 01/2021 - 01/2012
8	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 03/2009
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 05/2010
7	Messenger RNA (mRNA)IBA 01/2022 - 07/2014
6	Protein Kinases (Protein Kinase)IBA 01/2022 - 09/2014
6	EnzymesIBA 01/2021 - 05/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2011
6	palbociclibIBA 05/2018 - 01/2016
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2018 - 12/2010
5	PolymersIBA 08/2017 - 07/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2014 - 11/2007
5	CeramidesIBA 06/2010 - 05/2007
4	Histone Deacetylase InhibitorsIBA 09/2017 - 02/2011
4	LigandsIBA 05/2017 - 01/2014
4	(2- (4- methoxyphenyl)- 4- quinolinyl)(2- piperidinyl)methanolIBA 10/2015 - 10/2009
4	Dextrans (Dextran)FDA Link 01/2015 - 11/2009
4	CytokinesIBA 01/2014 - 09/2006
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2011 - 08/2009
4	bardoxolone methylIBA 08/2010 - 03/2009
3	Methylnitronitrosoguanidine (MNNG)IBA 05/2022 - 01/2018
3	AntigensIBA 01/2020 - 07/2003
3	CyclinsIBA 01/2020 - 05/2015
3	Keratins (Keratin)IBA 01/2020 - 06/2010
3	Cyclin-Dependent Kinase 9IBA 01/2019 - 01/2019
3	SurvivinIBA 01/2019 - 11/2006
3	B7-H1 AntigenIBA 01/2019 - 05/2015
3	Cyclin-Dependent Kinase 4IBA 05/2018 - 01/2018
3	Hyaluronic Acid (Hyaluronan)IBA 01/2018 - 02/2015
3	Antineoplastic Agents (Antineoplastics)IBA 09/2017 - 03/2013
3	Untranslated RNA (Noncoding RNA)IBA 09/2017 - 12/2016
3	abexinostatIBA 04/2015 - 02/2011
3	LipidsIBA 01/2015 - 11/2009
3	Indicators and Reagents (Reagents)IBA 01/2013 - 06/2010
3	Brachyury protein (Brachyury)IBA 01/2013 - 01/2011
3	AcidsIBA 08/2010 - 11/2007
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2010 - 11/2006
3	PM 00104IBA 06/2010 - 05/2009
3	TrabectedinIBA 06/2010 - 05/2009
2	RNA Polymerase II (RNA Polymerase B)IBA 05/2022 - 01/2020
2	berzosertibIBA 01/2022 - 01/2020
2	OTS514IBA 12/2021 - 10/2020
2	VimentinIBA 01/2020 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2010
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 08/2009
2	Therapeutic UsesIBA 01/2019 - 06/2017
2	Apoptosis Regulatory ProteinsIBA 01/2019 - 02/2016
2	Long Noncoding RNAIBA 01/2019 - 03/2017
2	Androgen Receptors (Androgen Receptor)IBA 08/2018 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 03/2018 - 12/2010
2	Biocompatible Materials (Biomaterials)IBA 08/2017 - 06/2015
2	Coloring Agents (Dyes)IBA 01/2016 - 04/2014
2	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015 - 03/2013
2	Carrier Proteins (Binding Protein)IBA 10/2014 - 06/2012
2	Nucleic AcidsIBA 08/2014 - 01/2014
2	PI103IBA 01/2014 - 06/2009
2	Caspase 3 (Caspase-3)IBA 04/2011 - 05/2010
2	lonidamineIBA 02/2011 - 01/2011

Therapy/Procedure

53	Therapeutics 02/2022 - 05/2003
48	Drug Therapy (Chemotherapy) 05/2022 - 07/2003
10	Radiotherapy 04/2019 - 02/2011
6	Neoadjuvant Therapy 12/2020 - 12/2010
4	Aftercare (After-Treatment) 02/2016 - 09/2009
2	Immunotherapy 01/2020 - 07/2003
2	Precision Medicine 12/2018 - 01/2011
2	Adjuvant Chemotherapy 06/2013 - 05/2010